-

Global Vitreo Retinal Surgery Devices Pipeline Report 2022 Update: Formulate Significant Competitor Information, Analysis, and Insights to Improve R&D Strategies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Vitreo Retinal Surgery Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update" report has been added to ResearchAndMarkets.com's offering.

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Vitreo Retinal Surgery Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Scope

  • Extensive coverage of the Vitreo Retinal Surgery Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Vitreo Retinal Surgery Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry

Key Topics Covered:

1 Table of Contents

2 Introduction

3 Products under Development

3.1 Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development

3.2 Vitreo Retinal Surgery Devices - Pipeline Products by Territory

3.3 Vitreo Retinal Surgery Devices - Pipeline Products by Regulatory Path

3.4 Vitreo Retinal Surgery Devices - Pipeline Products by Estimated Approval Date

3.5 Vitreo Retinal Surgery Devices - Ongoing Clinical Trials

4 Vitreo Retinal Surgery Devices - Pipeline Products under Development by Companies

4.1 Vitreo Retinal Surgery Devices Companies - Pipeline Products by Stage of Development

4.2 Vitreo Retinal Surgery Devices - Pipeline Products by Stage of Development

5 Vitreo Retinal Surgery Devices Companies and Product Overview

5.1 ABVC BioPharma Inc Company Overview

5.2 AcuSurgical Company Overview

5.3 Alcon Inc Company Overview

5.4 Bausch & Lomb Inc Company Overview

5.5 Beaver-Visitec International Inc Company Overview

5.6 Boston College Company Overview

5.7 Cambridge Polymer Group Inc Company Overview

5.8 Carnegie Mellon University Company Overview

5.9 Duke University Company Overview

5.10 Dutch Ophthalmic Research Center International BV Company Overview

5.11 Johns Hopkins University Company Overview

5.12 King's College London Company Overview

5.13 Medisse BV (Inactive) Company Overview

5.14 RetinaSense Company Overview

5.15 Synergetics USA, Inc. (Inactive) Company Overview

5.16 The Chinese University of Hong Kong Company Overview

5.17 University of Kansas Company Overview

5.18 University of Minnesota Company Overview

6 Vitreo Retinal Surgery Devices- Recent Developments

7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/zd122m

Source: GlobalData

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Medical Device Regulations in Asia-Pacific Markets Training Course: Knowledge and Practical Guidance Needed to Navigate Compliance and Successfully Access These High-growth Markets (Mar 3-4, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Medical Device Regulations in Asia-Pacific Markets Training Course (Mar 3rd - Mar 4th, 2026)" training has been added to ResearchAndMarkets.com's offering. With the European medical device market now well established, the next major opportunity lies in the Asia-Pacific region. Countries like China, Hong Kong, and Singapore have introduced - or are in the process of implementing - their own medical device regulations, shaping the future of market access. This semina...

IoT Mobile Virtual Network Operators (MVNO) Market Business Report 2025-2030: Growth in Smart Cities and Connected Utilities Drives Adoption of IoT MVNO Services - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "IoT Mobile Virtual Network Operators (MVNO) Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for IoT Mobile Virtual Network Operators (MVNO) was valued at US$2.7 Billion in 2024 and is projected to reach US$6.5 Billion by 2030, growing at a CAGR of 15.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed busine...

AI Hardware Industry Report 2025-2035: Regional Market Sizing and Opportunity Analysis, Competitive Landscape, Company Profiles, SWOT Analysis - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "AI Hardware Market Till 2035: Industry Trends and Global Forecasts" has been added to ResearchAndMarkets.com's offering. The global AI hardware market is poised for exponential growth, expanding from USD 31.40 billion in the current year to a projected USD 624.4 billion by 2035, achieving a CAGR of 31.23%. This surge is driven by increasing demand for advanced processing capabilities to support intricate AI workloads and computational tasks. AI Hardware Market: Gro...
Back to Newsroom